Exelixis (EXEL) Tops Q4 Earnings Estimates

Exelixis (EXEL) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of$ 0.31 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.45%. A quarter ago, it was expected that this drug developer would post earnings of$ 0.17 per share when it actually produced earnings of $0.10, delivering a surprise of -41.18%.Over the last four quarters, the company has ...